[1]
F. Greco, P. Piacentini, A. Remo, A. Bonetti, and G. Ferrandina, “Case 2 – Trabectedin as a maintenance therapy in a patient with recurrent ovarian cancer and BRCA1 germline mutation:  ”, CBN, vol. 4, no. 1, pp. 41–44, Mar. 2016.